$13.22
▼ -0.3% Today
as of Aug 5, 16:48 ET
Last 30 days
Recent Press Releases & News
Alpha Tau Medical (DRTS) Is Down 5.7% After Early-Stop Success In Alpha DaRT Combo Trial
Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's Pre-Specified Threshold for Success
Alpha Tau Medical Treats First Immunocompromised Patient in Alpha DaRT Study
Overview
52-week range
$2.81
$12
100% of range
Avg surprise (last 3)
-31.3%
Avg reaction (last 2)
+4.0%
50% positive
Latest IV / EM
95%
EM ±15.8% · $13 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 18, 2026 | Mar/2026 | $-0.26 | $-0.13 | -100.0% | -116.7% | -3.2% | earnings |
| Mon Aug 11, 2025 | Jun/2025 | $-0.13 | $-0.12 | -8.3% | — | — | earnings |
| Mon May 19, 2025 | Mar/2025 | $-0.12 | $-0.14 | +14.3% | — | +11.1% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 10, 2026 | Jun/2026 | OTHER | -$0.14 | -$0.13 | -7.7% |